Mammalian  prions

References

• Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 2001; 24:519 - 550
   PubMed Web of Science ®Google Scholar
• Aguzzi A, Calella AM. Prions: protein aggregation and infectious diseases. Physiol Rev 2009; 89:1105 - 1152
   PubMed Web of Science ®Google Scholar
• Soto C, Castilla J. The controversial protein-only hypothesis of prion propagation. Nat Med 2004; 10:63 - 67
   PubMed Web of Science ®Google Scholar
• Chesebro B. Prion protein and the transmissible spongiform encephalopathy diseases. Neuron 1999; 24:503 - 506
   PubMed Web of Science ®Google Scholar
• Griffith JS. Self-replication and scrapie. Nature 1967; 215:1043 - 1044
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Prions. Proc Natl Acad Sci USA 1998; 95:13363 - 13383
   PubMed Web of Science ®Google Scholar
• Diaz-Espinoza R, Soto C. Generation of prions in vitro and the protein-only hypothesis. Prion 2010; 4:53 - 59
   PubMed Web of Science ®Google Scholar
• Bolton DC, McKinley MP, Prusiner SB. Identification of a protein that purifies with the scrapie prion. Science 1982; 218:1309 - 1311
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Chemistry and biology of prions. Biochemistry 1992; 31:12277 - 12288
   PubMed Web of Science ®Google Scholar
• Aguzzi A, Heikenwalder M, Polymenidou M. Insights into prion strains and neurotoxicity. Nat Rev Mol Cell Biol 2007; 8:552 - 561
   PubMed Web of Science ®Google Scholar
• Merz PA, Somerville RA, Wisniewski HM, Iqbal K. Abnormal fibrils from scrapie-infected brain. Acta Neuropathol (Berl) 1981; 54:63 - 74
   PubMed Web of Science ®Google Scholar
• Prusiner SB, McKinley MP, Bowman KA, Bolton DC, Bendheim PE, Groth DF, et al. Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 1983; 35:349 - 358
   PubMed Web of Science ®Google Scholar
• McKinley MP, Meyer RK, Kenaga L, Rahbar F, Cotter R, Serban A, et al. Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis. J Virol 1991; 65:1340 - 1351
   PubMed Web of Science ®Google Scholar
• Barron RM, Campbell SL, King D, Bellon A, Chapman KE, Williamson RA, et al. High titers of transmissible spongiform encephalopathy infectivity associated with extremely low levels of PrPSc in vivo. J Biol Chem 2007; 282:35878 - 35886
   PubMed Web of Science ®Google Scholar
• Lasmezas CI, Deslys JP, Robain O, Jaegly A, Beringue V, Peyrin JM, et al. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 1997; 275:402 - 405
   PubMed Web of Science ®Google Scholar
• Tixador P, Herzog L, Reine F, Jaumain E, Chapuis J, Le Dur A, et al. The physical relationship between infectivity and prion protein aggregates is strain-dependent. PLoS Pathog 2010; 6:1000859
   PubMed Web of Science ®Google Scholar
• Safar J, Wille H, Itri V, Groth D, Serban H, Torchia M, et al. Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med 1998; 4:1157 - 1165
   PubMed Web of Science ®Google Scholar
• Parchi P, Cescatti M, Notari S, Schulz-Schaeffer WJ, Capellari S, Giese A, et al. Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease. Brain 2010; 133:3030 - 3042
   PubMed Web of Science ®Google Scholar
• Li J, Browning S, Mahal SP, Oelschlegel AM, Weissmann C. Darwinian evolution of prions in cell culture. Science 2010; 327:869 - 872
   PubMed Web of Science ®Google Scholar
• Vilette D. Cell models of prion infection. Vet Res 2008; 39:10
   PubMed Web of Science ®Google Scholar
• Vilette D, Andreoletti O, Archer F, Madelaine MF, Vilotte JL, Lehmann S, et al. Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein. Proc Natl Acad Sci USA 2001; 98:4055 - 4059
   PubMed Web of Science ®Google Scholar
• Cronier S, Laude H, Peyrin JM. Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death. Proc Natl Acad Sci USA 2004; 101:12271 - 12276
   PubMed Web of Science ®Google Scholar
• Arellano-Anaya ZA. A simple, versatile and sensitive cell-based assay for prions from various species. PLoS One 2011; 6:e20563
   Google Scholar
• Arellano Anaya ZE, Savistchenko J, Massonneau V, Lacroux C, Andreoletti O, Vilette D. Recovery of small infectious PrPres aggregates from prion-infected cultured cells. J Biol Chem 2011; 86:8141 - 8148
   Web of Science ®Google Scholar
• Courageot MP, Daude N, Nonno R, Paquet S, Di Bari MA, Le Dur A, et al. A cell line infectible by prion strains from different species. J Gen Virol 2008; 89:341 - 347
   PubMedGoogle Scholar
• Gabizon R, McKinley MP, Prusiner SB. Purified prion proteins and scrapie infectivity copartition into liposomes. Proc Natl Acad Sci USA 1987; 84:4017 - 4021
   PubMed Web of Science ®Google Scholar
• Manousis T, Verghese-Nikolakaki S, Keyes P, Sachsamanoglou M, Dawson M, Papadopoulos O, et al. Characterization of the murine BSE infectious agent. J Gen Virol 2000; 81:1615 - 1620
   PubMed Web of Science ®Google Scholar
• Riesner D, Kellings K, Post K, Wille H, Serban H, Groth D, et al. Disruption of prion rods generates 10-nm spherical particles having high alpha-helical content and lacking scrapie infectivity. J Virol 1996; 70:1714 - 1722
   PubMed Web of Science ®Google Scholar
• Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, Hayes SF, et al. The most infectious prion protein particles. Nature 2005; 437:257 - 261
   PubMed Web of Science ®Google Scholar
• Lee S, Fernandez EJ, Good TA. Role of aggregation conditions in structure, stability and toxicity of intermediates in the Abeta fibril formation pathway. Protein Sci 2007; 16:723 - 732
   PubMed Web of Science ®Google Scholar
• Chernoff YO, Lindquist SL, Ono B, Inge-Vechtomov SG, Liebman SW. Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]. Science 1995; 268:880 - 884
   PubMed Web of Science ®Google Scholar
• Krammer C, Schatzl HM, Vorberg I. Prion-like propagation of cytosolic protein aggregates: insights from cell culture models. Prion 2009; 3:206 - 212
   PubMed Web of Science ®Google Scholar
• Fevrier B, Vilette D, Archer F, Loew D, Faigle W, Vidal M, et al. Cells release prions in association with exosomes. Proc Natl Acad Sci USA 2004; 101:9683 - 9688
   PubMed Web of Science ®Google Scholar
• Fevrier B, Raposo G. Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr Opin Cell Biol 2004; 16:415 - 421
   PubMed Web of Science ®Google Scholar
• Fevrier B, Vilette D, Laude H, Raposo G. Exosomes: a bubble ride for prions?. Traffic 2005; 6:10 - 17
   PubMed Web of Science ®Google Scholar
• Cronier S, Gros N, Tattum MH, Jackson GS, Clarke AR, Collinge J, et al. Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin. Biochem J 2008; 416:297 - 305
   Google Scholar
• Deleault AM, Deleault NR, Harris BT, Rees JR, Supattapone S. The effects of prion protein proteolysis and disaggregation on the strain properties of hamster scrapie. J Gen Virol 2008; 89:2642 - 2650
   PubMed Web of Science ®Google Scholar
• D'Castro L, Wenborn A, Gros N, Joiner S, Cronier S, Collinge J, et al. Isolation of proteinase K-sensitive prions using pronase E and phosphotungstic acid. PLoS One 2010; 5:15679
   PubMed Web of Science ®Google Scholar
• Pirisinu L, Di Bari M, Marcon S, Vaccari G, D'Agostino C, Fazzi P, et al. A new method for the characterization of strain-specific conformational stability of protease-sensitive and protease-resistant PrP. PLoS One 2010; 5:12723
   PubMed Web of Science ®Google Scholar
• Thackray AM, Hopkins L, Bujdoso R. Proteinase K-sensitive disease-associated ovine prion protein revealed by conformation-dependent immunoassay. Biochem J 2007; 401:475 - 483
   PubMed Web of Science ®Google Scholar
• Tzaban S, Friedlander G, Schonberger O, Horonchik L, Yedidia Y, Shaked G, et al. Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes. Biochemistry 2002; 41:12868 - 12875
   PubMed Web of Science ®Google Scholar
• Pastrana MA, Sajnani G, Onisko B, Castilla J, Morales R, Soto C, et al. Isolation and characterization of a proteinase K-sensitive PrPSc fraction. Biochemistry 2006; 45:15710 - 15717
   PubMed Web of Science ®Google Scholar
• Safar JG, Geschwind MD, Deering C, Didorenko S, Sattavat M, Sanchez H, et al. Diagnosis of human prion disease. Proc Natl Acad Sci USA 2005; 102:3501 - 3506
   PubMed Web of Science ®Google Scholar
• Colby DW, Wain R, Baskakov IV, Legname G, Palmer CG, Nguyen HO, et al. Protease-sensitive synthetic prions. PLoS Pathog 2010; 6:1000736
   PubMed Web of Science ®Google Scholar
• Soto C, Satani N. The intricate mechanisms of neurodegeneration in prion diseases. Trends Mol Med 2010; In press
   Web of Science ®Google Scholar
• Collinge J, Clarke AR. A general model of prion strains and their pathogenicity. Science 2007; 318:930 - 936
   PubMed Web of Science ®Google Scholar
• Sandberg MK, Al-Doujaily H, Sharps B, Clarke AR, Collinge J. Prion propagation and toxicity in vivo occur in two distinct mechanistic phases. Nature 2011; 470:540 - 542
   PubMed Web of Science ®Google Scholar
• Solomon IH, Schepker JA, Harris DA. Prion neurotoxicity: insights from prion protein mutants. Curr Issues Mol Biol 2010; 12:51 - 61
   PubMed Web of Science ®Google Scholar
• Caughey B, Lansbury PT. Protofibrils, pores, fibrils and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci 2003; 26:267 - 298
   PubMed Web of Science ®Google Scholar